Ahmed Elkhanany, MD

Ahmed Elkhanany, MD

Oncology in Birmingham, AL

Hide Show

Speaks English and Arabic


 (205) 934-3411

Contact


Hide Show

Office Hours

Monday:
8:00 am - 5:00 pm
Tuesday:
1:00 pm - 5:00 pm
Wednesday:
Closed
Thursday:
8:00 am - 12:00 pm
Friday:
Closed
Saturday:
Closed
Sunday:
Closed
Hide Show

About Dr. Elkhanany


Dr. Ahmed Elkhanany, MD is an oncologist in Buffalo, New York. He is currently licensed to practice medicine in New York. He is affiliated with Roswell Park Cancer Institute.

Dr. Elkhanany pasion about Oncology started in his younger years, where he was drawn to the complexity and self organizational properties of tumors. Eventually, he perused research in Angiogenesis, the process by which tumors create new blood vessels to continue their growth. His interest shifted to Breast Cancer, where he studied the nature of breast tumors that lack receptors against which target therapy can work.

During his fellowship, Dr. Elkhanany has been pursuing his interest in Breast Cancer, as well as Tumor Micro-environment surrounding cancer cells.

Qualifications and Experience



Hide Show

Education & Training

Roswell Park Cancer Institute
Fellowship, Medical Oncology, 2016 - 2019

University of Missouri at Kansas City
Residency, Internal Medicine, 2013 - 2016

Mayo School of Graduate Medical Education
Post-Doctoral Fellowship, Breast Cancer Translational Group, 2012 - 2013

Alexandria Univ- Fac Med
Class of 2011

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Certifications

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

AL State Medical License
2019 - 2020

NY State Medical License
2016 - 2018

MO State Medical License
2013 - 2016

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Hospital Affiliations

University of Alabama Hospital
Current Affiliation
Birmingham, AL

Roswell Park Comprehensive Cancer Center
Former Affiliation
Buffalo, NY

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Gold Humanism Honor Member
Gold Humanism Honor Society, 2015

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Professional Memberships

American Medical Association - AMA
Member

American Society of Clinical Oncology - ASCO
Member

American Society of Hematology - ASH
Member

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer.
International journal of molecular sciences
Gandhi S, Elkhanany A, Oshi M, Dai T, Opyrchal M, Mohammadpour H, Repasky EA, Takabe K
6/30/2020

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Journal of the National Comprehensive Cancer Network : JNCCN
Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD

Primary and secondary breast angiosarcoma: single center report and a meta-analysis.
Breast cancer research and treatment
Abdou Y, Elkhanany A, Attwood K, Ji W, Takabe K, Opyrchal M
9/14/2019

See All

Lecture

Racial disparity in breast cancer immune microenvironment.
06/2/2018
2018 ASCO Annual Meeting - Chicago, Illinois

Abstract

Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature
61st Annual American Society of Hematology Meeting
Ahmad Elkhanany
12/7/2019
Orlando, FL

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄